Deutsche Bank Ag\ Prothena Corp Public LTD CO Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Deutsche Bank Ag\ holds 32,458 shares of PRTA stock, worth $505,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,458

Previous 27,554 17.8%

Holding current value

$505,695

Previous $568,000 4.4%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$16.73 - $24.79 $82,043 - $121,570	4,904 Added 17.8%	32,458 $543,000
Q2 2024 Aug 14, 2024	SELL	$19.54 - $26.15 $84,862 - $113,569	-4,343 Reduced 13.62%	27,554 $568,000
Q1 2024 May 15, 2024	BUY	$24.75 - $40.66 $239,976 - $394,239	9,696 Added 43.67%	31,897 $790,000
Q4 2023 Feb 14, 2024	SELL	$32.31 - $52.32 $13,311 - $21,555	-412 Reduced 1.82%	22,201 $806,000
Q3 2023 Nov 09, 2023	BUY	$47.3 - $70.6 $135,136 - $201,704	2,857 Added 14.46%	22,613 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$48.26 - $78.59 $366,534 - $596,891	-7,595 Reduced 27.77%	19,756 $1.35 Million
Q1 2023 May 15, 2023	BUY	$46.97 - $58.27 $256,127 - $317,746	5,453 Added 24.9%	27,351 $1.33 Million
Q4 2022 Feb 13, 2023	BUY	$52.05 - $65.0 $292,468 - $365,235	5,619 Added 34.52%	21,898 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$25.16 - $60.63 $90,425 - $217,904	-3,594 Reduced 18.08%	16,279 $987,000
Q2 2022 Aug 11, 2022	SELL	$22.73 - $39.98 $56,165 - $98,790	-2,471 Reduced 11.06%	19,873 $539,000
Q1 2022 May 13, 2022	SELL	$30.27 - $49.22 $69,015 - $112,221	-2,280 Reduced 9.26%	22,344 $817,000
Q4 2021 Feb 11, 2022	SELL	$42.11 - $73.26 $295,780 - $514,578	-7,024 Reduced 22.19%	24,624 $1.22 Million
Q3 2021 Nov 04, 2021	BUY	$48.2 - $78.89 $483,735 - $791,740	10,036 Added 46.44%	31,648 $2.25 Million
Q2 2021 Aug 11, 2021	BUY	$21.63 - $57.65 $34,478 - $91,894	1,594 Added 7.96%	21,612 $1.11 Million
Q1 2021 May 13, 2021	SELL	$11.0 - $28.24 $80,993 - $207,931	-7,363 Reduced 26.89%	20,018 $502,000
Q4 2020 Feb 16, 2021	SELL	$10.12 - $13.94 $69,291 - $95,447	-6,847 Reduced 20.0%	27,381 $329,000
Q3 2020 Nov 12, 2020	SELL	$9.93 - $13.47 $340,718 - $462,182	-34,312 Reduced 50.06%	34,228 $342,000
Q2 2020 Aug 13, 2020	SELL	$9.56 - $12.51 $92,263 - $120,734	-9,651 Reduced 12.34%	68,540 $717,000
Q1 2020 May 14, 2020	SELL	$7.54 - $15.77 $36,139 - $75,585	-4,793 Reduced 5.78%	78,191 $837,000
Q4 2019 Feb 14, 2020	SELL	$7.48 - $17.01 $532,950 - $1.21 Million	-71,250 Reduced 46.2%	82,984 $1.31 Million
Q3 2019 Nov 14, 2019	SELL	$6.89 - $10.45 $674,358 - $1.02 Million	-97,875 Reduced 38.82%	154,234 $1.21 Million
Q2 2019 Aug 14, 2019	SELL	$8.85 - $12.49 $229,117 - $323,353	-25,889 Reduced 9.31%	252,109 $2.66 Million
Q1 2019 May 15, 2019	BUY	$10.32 - $14.49 $2.53 Million - $3.55 Million	245,019 Added 742.95%	277,998 $3.37 Million
Q4 2018 Feb 14, 2019	SELL	$8.73 - $13.74 $1.71 Million - $2.7 Million	-196,356 Reduced 85.62%	32,979 $339,000
Q3 2018 Dec 21, 2021	BUY	$12.7 - $15.79 $1.1 Million - $1.36 Million	86,353 Added 60.39%	229,335 $3 Million
Q3 2018 Nov 14, 2018	BUY	$12.7 - $15.79 $632,510 - $786,405	49,804 Added 53.45%	142,982 $1.87 Million
Q2 2018 Apr 21, 2020	BUY	$10.99 - $44.21 $221,767 - $892,113	20,179 Added 27.64%	93,178 $1.36 Million
Q2 2018 Aug 14, 2018	SELL	$10.99 - $44.21 $2 Million - $8.03 Million	-181,704 Reduced 71.34%	72,999 $1.06 Million
Q1 2018 Oct 18, 2019	BUY	$27.95 - $45.04 $2.04 Million - $3.29 Million	73,050 Added 40.21%	254,703 $9.35 Million
Q1 2018 May 15, 2018	SELL	$27.95 - $45.04 $1.39 Million - $2.24 Million	-49,815 Reduced 21.52%	181,653 $6.67 Million
Q4 2017 Feb 14, 2018	BUY	$35.44 - $63.76 $2.25 Million - $4.05 Million	63,537 Added 37.84%	231,468 $8.67 Million
Q3 2017 Nov 14, 2017	BUY	$53.83 - $67.75 $9.04 Million - $11.4 Million	167,931	167,931 $10.9 Million

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $731M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account